Patents by Inventor Jean-Marc Guillaume

Jean-Marc Guillaume has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10445668
    Abstract: A computer readable medium for analyzing and predicting the future behavior of Organizations, where an embodiment of this invention is comprised of one or more repositories of data which involve comments or other actions by actors with some kind of relationship to a target organization, a repository of metadata relating to this data, a repository of updatable models of organizations, a natural language parsing engine, an engine for generating and comparing the organizational models, and presentations of avatars.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: October 15, 2019
    Inventors: Richard Oehrle, Steven L. Roberts, Katya Saint-Amand, Laurent Jean-Marc Guillaume Dupont
  • Publication number: 20180189691
    Abstract: A computer readable medium for analyzing and predicting the future behavior of organizations is disclosed. An embodiment of this invention is comprised of one or more repositories of data which involve comments or other actions by actors with some kind of relationship to a target organization, a repository of metadata relating to this data, a repository of updatable models of organizations, a natural language parsing engine, an engine for generating and comparing the organizational models, and presentations of avatars.
    Type: Application
    Filed: January 4, 2017
    Publication date: July 5, 2018
    Inventors: Richard Oehrle, Steven L. Roberts, Katya Saint-Amand, Laurent Jean-Marc Guillaume Dupont
  • Patent number: 9569729
    Abstract: A computer readable medium for analyzing and predicting the future behavior of organizations is disclosed. An embodiment of this invention is comprised of one or more repositories of data which involve comments or other actions by actors with some kind of relationship to a target organization, a repository of metadata relating to this data, a repository of updatable models of organizations, a natural language parsing engine, and an engine for generating and comparing the organizational models.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: February 14, 2017
    Assignee: Chenope, Inc.
    Inventors: Richard Oehrle, Steven Lee Roberts, Elizabeth B Charnock, Katya Saint-Amand, Laurent Jean-Marc Guillaume Dupont
  • Publication number: 20080064095
    Abstract: The present application relates to a method for obtaining mastocyte cultures or lines. It also relates to a method for producing heparin-type molecules, comprising the culturing of mastocyte cultures or lines.
    Type: Application
    Filed: November 12, 2007
    Publication date: March 13, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Jean-Marc GUILLAUME, Werner DITTRICH, Sandrine PEREZ, Christine Michelle ANDREONI, Romain PAILLOT
  • Publication number: 20050287657
    Abstract: The invention concerns a method for producing recombinant adenovirus by which viral DNA is introduced in a packaging cell culture and the viruses produced are harvested after liberation in the supernatant. The invention also concerns the viruses produced and their use.
    Type: Application
    Filed: March 23, 2005
    Publication date: December 29, 2005
    Inventors: Francis Blanche, Jean-Marc Guillaume
  • Publication number: 20050181484
    Abstract: The present application relates to a method for obtaining mastocyte cultures or lines. It also relates to a method for producing heparin-type molecules, comprising the culturing of mastocyte cultures or lines.
    Type: Application
    Filed: April 13, 2004
    Publication date: August 18, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Jean-Marc Guillaume, Werner Dittrich, Sandrine Perez, Christine Andreoni, Romain Paillot
  • Patent number: 6905862
    Abstract: The invention concerns a method for producing recombinant adenovirus by which viral DNA is introduced in a packaging cell culture and the viruses produced are harvested after liberation in the supernatant. The invention also concerns the viruses produced and their use.
    Type: Grant
    Filed: October 10, 2002
    Date of Patent: June 14, 2005
    Assignee: Centelion
    Inventors: Francis Blanche, Jean-Marc Guillaume
  • Publication number: 20050042733
    Abstract: The invention concerns the production of heparin from mast cell cultures, in particular pig mast cells.
    Type: Application
    Filed: October 22, 2002
    Publication date: February 24, 2005
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Pierre Cans, Jean-Marc Guillaume, Helene Rigal
  • Publication number: 20030143730
    Abstract: The invention concerns a method for producing recombinant adenovirus by which viral DNA is introduced in a packaging cell culture and the viruses produced are harvested after liberation in the supernatant. The invention also concerns the viruses produced and their use.
    Type: Application
    Filed: October 10, 2002
    Publication date: July 31, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Francis Blanche, Jean-Marc Guillaume
  • Patent number: 6485958
    Abstract: The invention concerns a method for producing recombinant adenovirus by which viral DNA is introduced in a packaging cell culture and the viruses produced are harvested after liberation in the supernatant. The invention also concerns the viruses produced and their use.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: November 26, 2002
    Inventors: Francis Blanche, Jean-Marc Guillaume
  • Publication number: 20020028497
    Abstract: The invention concerns a method for producing recombinant adenovirus by which viral DNA is introduced in a packaging cell culture and the viruses produced are harvested after liberation in the supernatant. The invention also concerns the viruses produced and their use.
    Type: Application
    Filed: December 16, 1998
    Publication date: March 7, 2002
    Inventors: FRANCIS BLANCHE, JEAN-MARC GUILLAUME
  • Patent number: 5631279
    Abstract: This invention relates to perhydroisoindole derivatives of 08/448,402 formula (I), wherein radicals R are phenyl radicals optionally 2-or 3-substituted by a halogen atom or a methyl radical; R.sub.1 is optionally substituted phenyl, cyclohexadienyl, naphthyl, indenyl or optionally substituted heterocyclyl; R.sub.2 is H, halogen, OH, alkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkoxy, alkylthio, acyloxy, acyloxy, carboxy, optionally substituted alkyloxycarbonyl, benzyloxycarbonyl, amino or acylamino; and R.sub.3 is optionally 2-substituted phenyl; optionally salts thereof where applicable; and preparation thereof. Said derivatives are particularly useful as neurokinin A antagonists.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 20, 1997
    Assignee: Rhone-Poulenc Rorer, S.A.
    Inventors: Andre Crespo, Veronique Fardin, Jean-Marc Guillaume, Jean-Luc Malleron, Jean-Francois Peyronel